Loutzenhiser R, Epstein M
Am J Physiol. 1985 Nov;249(5 Pt 2):F619-29. doi: 10.1152/ajprenal.1985.249.5.F619.
The renal hemodynamic effects of Ca2+ antagonists are considered in the context of their actions on Ca2+ movements during activation of vascular smooth muscle. Observations in intact animals reveal that the renal hemodynamic response to Ca2+ antagonists is highly variable, depending on the neural and hormonal determinants of renal vascular tone. Studies in the isolated perfused kidney and in isolated renal vessels indicate that diverse agonists use different activating mechanisms with differing sensitivities to Ca2+ antagonists. In comparison with other direct-acting vasodilators, Ca2+ antagonists are unique in their ability to maintain or increase glomerular filtration rate. This effect is due, in part, to their selective reduction of afferent arteriolar resistance. This implies that activating mechanisms of the afferent and efferent arterioles differ. The ability of Ca2+ antagonists to augment glomerular filtration rate by concomitant actions on nonvascular sites remains to be elucidated.
钙通道阻滞剂对肾脏血流动力学的影响是在其对血管平滑肌激活过程中钙运动的作用背景下进行考量的。在完整动物身上的观察结果表明,钙通道阻滞剂对肾脏血流动力学的反应高度可变,这取决于肾血管张力的神经和激素决定因素。在离体灌注肾脏和离体肾血管中的研究表明,不同的激动剂使用不同的激活机制,对钙通道阻滞剂的敏感性也不同。与其他直接作用的血管扩张剂相比,钙通道阻滞剂在维持或增加肾小球滤过率方面具有独特的能力。这种作用部分归因于它们对入球小动脉阻力的选择性降低。这意味着入球小动脉和出球小动脉的激活机制不同。钙通道阻滞剂通过对非血管部位的协同作用来提高肾小球滤过率的能力仍有待阐明。